Last reviewed · How we verify
Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab
Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab is a Small molecule drug developed by German CLL Study Group. It is currently in Phase 2 development. Also known as: Mabcampath, Fludarabine, Endoxan, Novantron.
At a glance
| Generic name | Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab |
|---|---|
| Also known as | Mabcampath, Fludarabine, Endoxan, Novantron |
| Sponsor | German CLL Study Group |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL) (PHASE2)
- Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab CI brief — competitive landscape report
- Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab updates RSS · CI watch RSS
- German CLL Study Group portfolio CI
Frequently asked questions about Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab
What is Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab?
Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab is a Small molecule drug developed by German CLL Study Group.
Who makes Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab?
Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab is developed by German CLL Study Group (see full German CLL Study Group pipeline at /company/german-cll-study-group).
Is Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab also known as anything else?
Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab is also known as Mabcampath, Fludarabine, Endoxan, Novantron.
What development phase is Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab in?
Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab is in Phase 2.
Related
- Manufacturer: German CLL Study Group — full pipeline
- Also known as: Mabcampath, Fludarabine, Endoxan, Novantron
- Compare: Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab vs similar drugs
- Pricing: Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab cost, discount & access